Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $5.876B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 9,295,000 | $1.002B | 17.0% | $48.54 | — | Common | G46188101 |
| — | MIRATI THERAPEUTICS INC | 5,075,000 | $744M | 12.7% | $51.83 | — | Common | 60468T105 |
| UTHR | UNITED THERAPEUTICS CORP | 3,035,000 | $656M | 11.2% | $133.73 | +46.8% | Common | 91307C102 |
| APLS | APELLIS PHARMACEUTICALS INC | 8,555,555 | $405M | 6.9% | $48.16 | -18.2% | Common | 03753U106 |
| ARGX | ARGENX SE | 965,000 | $338M | 5.8% | $83.19 | — | Sponsored ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,125,000 | $281M | 4.8% | $99.17 | -13.8% | Common | 803607100 |
| ASND | ASCENDIS PHARMA | 2,000,000 | $269M | 4.6% | $132.69 | — | Sponsored ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,800,000 | $247M | 4.2% | $83.48 | -1.2% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 18,500,000 | $214M | 3.6% | $11.30 | -1.3% | Common | 03152W109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,075,000 | $182M | 3.1% | $154.71 | +20.1% | Common | 02043Q107 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 8,675,000 | $166M | 2.8% | $16.48 | +33.6% | Common | 462260100 |
| XENE | XENON PHARMACEUTICALS INC | 4,985,000 | $156M | 2.7% | $16.29 | +83.4% | Common | 98420N105 |
| — | IVERIC BIO INC | 7,250,000 | $121M | 2.1% | $6.39 | — | Common | 46583P102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,425,000 | $121M | 2.1% | $124.06 | -33.8% | Common | 558868105 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 1,050,000 | $118M | 2.0% | $111.96 | — | ETF | 78464A870 |
| — | ARENA PHARMACEUTICALS INC | 1,235,000 | $115M | 2.0% | $72.64 | — | Common | 040047607 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,311,434 | $67.62M | 1.2% | $20.37 | +2.8% | Common | 61225M102 |
| KURA | KURA ONCOLOGY INC | 4,000,000 | $56M | 1.0% | $25.17 | -35.6% | Common | 50127T109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,200,000 | $51.35M | 0.9% | $48.41 | -58.4% | Common | 004225108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,175,000 | $47.61M | 0.8% | $20.70 | -10.7% | Common | 87164F105 |
| WHWK | AADI BIOSCIENCES INC | 1,829,402 | $44.18M | 0.8% | $30.48 | -17.6% | Common | 00032Q104 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $42.3M | 0.7% | $23.19 | — | Common | 59045L106 |
| MNKD | MANNKIND CORP | 8,800,000 | $38.46M | 0.7% | $3.55 | +30.3% | Common | 56400P706 |
| — | MARINUS PHARMACEUTICALS INC | 3,235,000 | $38.43M | 0.7% | $12.20 | — | Common | 56854Q200 |
| — | PRAXIS PRECISION MEDICINES INC | 1,780,000 | $35.07M | 0.6% | $41.53 | — | Common | 74006W108 |
| DSGN | DESIGN THERAPEUTICS INC | 1,636,100 | $35.03M | 0.6% | $29.71 | -42.2% | Common | 25056L103 |
| KYMR | KYMERA THERAPEUTICS INC | 550,000 | $34.92M | 0.6% | $58.02 | +0.4% | Common | 501575104 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $34.81M | 0.6% | $6.26 | — | Common | 23257D103 |
| PMVP | PMV PHARMACEUTICALS INC | 1,465,000 | $33.84M | 0.6% | $35.29 | -31.5% | Common | 69353Y103 |
| KRYS | KRYSTAL BIOTECH INC | 475,000 | $33.23M | 0.6% | $58.21 | 0.0% | Common | 501147102 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,230,000 | $29.24M | 0.5% | $25.02 | -4.5% | Common | 05370A108 |
| — | AMARIN CORP PLC | 6,000,000 | $20.22M | 0.3% | $8.22 | — | Sponsored ADR | 023111206 |
| NUVL | NUVALENT INC | 1,102,671 | $18.43M | 0.3% | $29.01 | -23.2% | Common | 670703107 |
| TNGX | TANGO THERAPEUTICS INC | 1,550,000 | $16.96M | 0.3% | $11.99 | +0.3% | Common | 87583X109 |
| — | DICE THERAPEUTICS INC | 562,500 | $14.24M | 0.2% | $32.75 | — | Common | 23345J104 |
| — | AVADEL PHARMACEUTICALS PLC | 1,670,000 | $13.49M | 0.2% | $7.90 | — | Sponsored ADR | 05337M104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $12.23M | 0.2% | $11.14 | — | Common | 00773U108 |
| IOBT | IO BIOTECH INC | 2,055,883 | $10.24M | 0.2% | $9.66 | 0.0% | Common | 449778109 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $5.898M | 0.1% | $2.62 | -43.2% | Common | 372427401 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $5.28M | 0.1% | $9.85 | -24.5% | Common | 31447P100 |
| SRPT | SAREPTA THERAPEUTICS INC | 300,000 | $2.91M | 0.0% | $99.17 | -13.8% | Call | 803607100 |